Company Filing History:
1 out of 30 
1 out of 20 Years Active: 2022
Title: The Innovative Contributions of Qianlei Cao in Sulfonamide Compound Development
Introduction: Qianlei Cao, an accomplished inventor based in Suzhou, China, has made significant strides in the field of medicinal chemistry. With his innovative approach and attention to detail, he has contributed to the development of a process for preparing sulfonamide compounds, particularly those that inhibit the Bcl-2/Bcl-xL proteins, which are critical targets in cancer therapy.
Latest Patents: Qianlei Cao holds a patent for a process that relates to the preparation of a sulfonamide compound, which includes the sophisticated structure identified as (3R)-1-(3-(4-(4-(4-(3-(2-(4-chlorophenyl)-1-isopropyl-4-methylsulfonyl-5-methyl-1H-pyrrol-3-yl)-5-fluorophenyl)piperazine-1-yl)-phenylaminosulfonyl)-2-trifluoromethanesulfonyl-anilino)-4-phenylthio-butyl)-piperidine-4-carboxylic acid 3-phosphonopropyl ester. This invention also discusses an intermediate for preparing the sulfonamide compound and a detailed preparation process.
Career Highlights: Qianlei Cao has had a distinguished career with notable positions at Ascentage Pharma (Suzhou) Co., Ltd. and Ascentage Pharma Group Corp Limited. His work in these organizations has been pivotal in advancing pharmaceutical research and development, with a focus on innovative treatments for various diseases.
Collaborations: Throughout his career, Qianlei has collaborated with esteemed colleagues such as Ming Guo and Jianfeng Wen. Their joint efforts have fostered a dynamic environment of research and innovation, contributing to the successful development of new medications and therapeutic strategies.
Conclusion: Qianlei Cao exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the development of sulfonamide compounds with potential cancer-fighting properties, reflect a deep commitment to improving healthcare outcomes. As he continues to push the boundaries of medicinal chemistry, the impact of his work will likely be felt for years to come.